Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) — Cash Flow Quality Index
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Cash Flow Quality Index of -8.02x as of June 2025. Operating cash flow of CN¥-30.06 Million is below net income of CN¥3.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Gansu Longshenrongfa Pharmaceutical Indu to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Gansu Longshenrongfa Pharmaceutical Indu.
Annual Cash Flow Quality Index for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2013–2025)
Year-by-year earnings quality comparison for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.15x | CN¥-6.54 Million | CN¥43.95 Million | ▼ -104.5% |
| 2024 | 3.28x | CN¥170.14 Million | CN¥51.91 Million | ▲ +184.7% |
| 2023 | 1.15x | CN¥96.53 Million | CN¥83.85 Million | ▲ +205.2% |
| 2022 | 0.38x | CN¥11.43 Million | CN¥30.30 Million | ▼ -97.2% |
| 2020 | 13.25x | CN¥43.50 Million | CN¥3.28 Million | ▲ +621.7% |
| 2019 | 1.84x | CN¥28.21 Million | CN¥15.36 Million | ▲ +120.3% |
| 2018 | 0.83x | CN¥10.23 Million | CN¥12.28 Million | ▲ +794.4% |
| 2017 | -0.12x | CN¥-2.05 Million | CN¥17.11 Million | ▼ -143.2% |
| 2016 | 0.28x | CN¥13.14 Million | CN¥47.25 Million | ▼ -44.9% |
| 2015 | 0.50x | CN¥30.60 Million | CN¥60.68 Million | ▼ -21.9% |
| 2014 | 0.65x | CN¥39.01 Million | CN¥60.42 Million | ▼ -26.5% |
| 2013 | 0.88x | CN¥35.92 Million | CN¥40.91 Million | — |